Literature DB >> 15256067

Inorganic phosphate homeostasis and the role of dietary phosphorus.

Eiji Takeda1, Hironori Yamamoto, Kunitaka Nashiki, Tadatoshi Sato, Hidekazu Arai, Yutaka Taketani.   

Abstract

Inorganic phosphate (Pi) is required for cellular function and skeletal mineralization. Serum Pi level is maintained within a narrow range through a complex interplay between intestinal absorption, exchange with intracellular and bone storage pools, and renal tubular reabsorption. The crucial regulated step in Pi homeostasis is the transport of Pi across the renal proximal tubule. Type II sodium-dependent phosphate (Na/Pi) cotransporter (NPT2) is the major molecule in the renal proximal tubule and is regulated by Pi, parathyroid hormone and by 1,25-dihydroxyvitamin D. Recent studies of inherited and acquired hypophosphatemia [X-linked hypophosphatemic rickets/osteomalacia (XLH), autosomal dominant hypophosphatemic rickets/osteomalacia (ADHR) and tumor-induced rickets/osteomalacia (TIO)], which exhibit similar biochemical and clinical features, have led to the identification of novel genes, PHEX and FGF23, that play a role in the regulation of Pi homeostasis. The PHEX gene, which is mutated in XLH, encodes an endopeptidase, predominantly expressed in bone and teeth, but not in kidney. FGF-23 may be a substrate of this endopeptidase and may therefore accumulate in patients with XLH. In the case of ADHR mutations in the furin cleavage site, which prevent the processing of FGF-23 into fragments, lead to the accumulation of a "stable" circulating form of the peptide which also inhibits renal Pi reabsorption. In the case of TIO, ectopic overproduction of FGF-23 overwhelms its processing and degradation by PHEX, leading to the accumulation of FGF-23 in the circulation and inhibition of renal Pi reabsorption. Mice homozygous for severely hypomorphic alleles of the Klotho gene exhibit a syndrome resembling human aging, including atherosclerosis, osteoporosis, emphysema, and infertility. The KLOTHO locus is associated with human survival, defined as postnatal life expectancy, and longevity, defined as life expectancy after 75. In considering the relationship of klotho expression to the dietary Pi level, the klotho protein seemed to be negatively controlled by dietary Pi.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15256067      PMCID: PMC6740209          DOI: 10.1111/j.1582-4934.2004.tb00274.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  48 in total

1.  Asymmetrical targeting of type II Na-P(i) cotransporters in renal and intestinal epithelial cell lines.

Authors:  N Hernando; S Sheikh; Z Karim-Jimenez; H Galliker; J Forgo; J Biber; H Murer
Journal:  Am J Physiol Renal Physiol       Date:  2000-03

Review 2.  Molecular mechanisms of mammalian inorganic phosphate homeostasis.

Authors:  E Takeda; Y Taketani; K Morita; S Tatsumi; K Katai; T Nii; H Yamamoto; K Miyamoto
Journal:  Adv Enzyme Regul       Date:  2000

3.  In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome.

Authors:  Y Saito; T Nakamura; Y Ohyama; T Suzuki; A Iida; T Shiraki-Iida; M Kuro-o; Y Nabeshima; M Kurabayashi; R Nagai
Journal:  Biochem Biophys Res Commun       Date:  2000-09-24       Impact factor: 3.575

4.  The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting.

Authors:  K E White; K B Jonsson; G Carn; G Hampson; T D Spector; M Mannstadt; B Lorenz-Depiereux; A Miyauchi; I M Yang; O Ljunggren; T Meitinger; T M Strom; H Jüppner; M J Econs
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

5.  Rapid downregulation of rat renal Na/P(i) cotransporter in response to parathyroid hormone involves microtubule rearrangement.

Authors:  M Lötscher; Y Scarpetta; M Levi; N Halaihel; H Wang; H K Zajicek; J Biber; H Murer; B Kaissling
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

6.  Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases.

Authors:  R Nagai; Y Saito; Y Ohyama; H Aizawa; T Suga; T Nakamura; M Kurabayashi; M Kuroo
Journal:  Cell Mol Life Sci       Date:  2000-05       Impact factor: 9.261

7.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.

Authors: 
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

8.  PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia.

Authors:  T D Blydt-Hansen; H S Tenenhouse; P Goodyer
Journal:  Pediatr Nephrol       Date:  1999-09       Impact factor: 3.714

9.  Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain.

Authors:  T Yamashita; M Yoshioka; N Itoh
Journal:  Biochem Biophys Res Commun       Date:  2000-10-22       Impact factor: 3.575

Review 10.  X-linked hypophosphataemia: a homologous disorder in humans and mice.

Authors:  H S Tenenhouse
Journal:  Nephrol Dial Transplant       Date:  1999-02       Impact factor: 5.992

View more
  31 in total

1.  Effects of transgenic Pit-1 overexpression on calcium phosphate and bone metabolism.

Authors:  Atsushi Suzuki; Patrick Ammann; Keiko Nishiwaki-Yasuda; Sahoko Sekiguchi; Shogo Asano; Shizuko Nagao; Ryosuke Kaneko; Masumi Hirabayashi; Yutaka Oiso; Mitsuyasu Itoh; Joseph Caverzasio
Journal:  J Bone Miner Metab       Date:  2009-10-01       Impact factor: 2.626

Review 2.  Renal and extrarenal actions of Klotho.

Authors:  Ming Chang Hu; Makoto Kuro-o; Orson W Moe
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

3.  Hypophosphatemic rickets: results of a long-term follow-up.

Authors:  Maria Helena Vaisbich; Vera H Koch
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

4.  All-trans retinoic acid reduces the transcriptional regulation of intestinal sodium-dependent phosphate co-transporter gene (Npt2b).

Authors:  Masashi Masuda; Hironori Yamamoto; Yuichiro Takei; Otoki Nakahashi; Yuichiro Adachi; Kohta Ohnishi; Hirokazu Ohminami; Hisami Yamanaka-Okumura; Hiroshi Sakaue; Makoto Miyazaki; Eiji Takeda; Yutaka Taketani
Journal:  Biochem J       Date:  2020-02-28       Impact factor: 3.857

5.  Association of serum inorganic phosphate with sex steroid hormones and vitamin D in a nationally representative sample of men.

Authors:  W Wulaningsih; M Van Hemelrijck; K Michaelsson; N Kanarek; W G Nelson; J H Ix; E A Platz; S Rohrmann
Journal:  Andrology       Date:  2014-10-01       Impact factor: 3.842

6.  Elevated inorganic phosphate stimulates Akt-ERK1/2-Mnk1 signaling in human lung cells.

Authors:  Seung-Hee Chang; Kyeong Nam Yu; Yeon-Sook Lee; Gil-Hwan An; George R Beck; Nancy H Colburn; Kee-Ho Lee; Myung-Haing Cho
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-08       Impact factor: 6.914

7.  Protein lysine-Nζ alkylation and O-phosphorylation mediated by DTT-generated reactive oxygen species.

Authors:  Nigam Kumar; Hans Ippel; Christian Weber; Tilman Hackeng; Kevin H Mayo
Journal:  Protein Sci       Date:  2013-01-27       Impact factor: 6.725

8.  High dietary inorganic phosphate increases lung tumorigenesis and alters Akt signaling.

Authors:  Hua Jin; Cheng-Xiong Xu; Hwang-Tae Lim; Sung-Jin Park; Ji-Young Shin; Youn-Sun Chung; Se-Chang Park; Seung-Hee Chang; Hee-Jeong Youn; Kee-Ho Lee; Yeon-Sook Lee; Yoon-Cheol Ha; Chan-Hee Chae; George R Beck; Myung-Haing Cho
Journal:  Am J Respir Crit Care Med       Date:  2008-10-10       Impact factor: 21.405

Review 9.  Klotho.

Authors:  Makoto Kuro-o
Journal:  Pflugers Arch       Date:  2010-01       Impact factor: 3.657

10.  Low dietary inorganic phosphate affects the lung growth of developing mice.

Authors:  Cheng Xiong Xu; Hua Jin; Youn Sun Chung; Ji Young Shin; Soon Kyung Hwang; Jung Taek Kwon; Sung Jin Park; Eun Sun Lee; Arash Minai-Tehrani; Seung Hee Chang; Min Ah Woo; Mi Suk Noh; Gil Hwan An; Kee Ho Lee; Myung Haing Cho
Journal:  J Vet Sci       Date:  2009-06       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.